Emory University Iovance Biotherapeutics, Inc. Transaction History

Emory University

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$17.99 - $26.0 $2.36 Million - $3.41 Million	-131,041 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$9.78 - $24.52 $976,542 - $2.45 Million	-99,851 Reduced 43.25%	131,041 $3.21 Million
Q1 2019 May 09, 2019	SELL	$8.41 - $11.26 $140,867 - $188,605	-16,750 Reduced 6.76%	230,892 $2.2 Million
Q4 2018 Feb 12, 2019	BUY	$7.51 - $11.93 $1.86 Million - $2.95 Million	247,642 New	247,642 $2.19 Million

306

221M

3.05M

1.6M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.23B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Emory University, based on Form 13F filings with the SEC.

Stay updated on Emory University with notifications on news.